文献速递慢性肾脏病血液净化与透析

肾脏疾病中嗅觉缺陷的特征与纠正

Characterization and Correction of Olfactory Deficits in Kidney Disease.
PubMed 文献 · J Am Soc Nephrol · 2017-08-03

该研究纳入161人(CKD 36例、ESRD 100例、对照25例),发现CKD和ESRD患者嗅觉识别评分低于对照,且肾脏疾病与嗅觉识别缺陷风险升高相关。嗅觉识别评分降低与主观全局评估评分升高及血清总胆固醇、LDL胆固醇和白蛋白降低相关。鼻用茶碱初步试验中7例ESRD患者有5例嗅觉识别评分改善。

要点

  • CKD和ESRD患者存在嗅觉识别缺陷,可能影响营养状态。
  • 肾脏疾病与嗅觉识别缺陷风险升高相关(OR 4.80,95%CI 1.94-11.89)。
  • 鼻用茶碱初步试验显示ESRD患者嗅觉识别评分改善,需随机对照试验证实。

核心结论

  • 肾脏疾病患者存在嗅觉缺陷,可能影响其营养状态。
  • 鼻用茶碱改善嗅觉的初步结果需随机对照试验确认。

研究设计与样本

  • 队列研究纳入161人:CKD 36例、ESRD 100例、对照25例。
  • 另进行一项6周、开放标签、概念验证临床试验,鼻用茶碱干预ESRD患者。

主要发现

  • 平均嗅觉识别评分:CKD组75.6%±13.1%(P=0.02),ESRD组66.8%±15.1%(P<0.001),均低于对照组83.6%±11.4%。
  • ESRD患者嗅觉阈值高于其他参与者。
  • 所有组主观嗅觉评估评分相似。
  • 多变量调整分析中,肾脏疾病与嗅觉识别缺陷风险升高相关(OR 4.80,95%CI 1.94-11.89)。
  • 嗅觉识别评分降低与主观全局评估评分升高及血清总胆固醇、LDL胆固醇、白蛋白降低相关;嗅觉阈值与营养参数无关联。

临床怎么用

  • 对CKD和ESRD患者应关注嗅觉缺陷及其对营养状态的潜在影响。
  • 鼻用茶碱目前仅为初步探索,不应常规用于改善嗅觉。

局限性

  • 鼻用茶碱研究为开放标签、概念验证试验,样本量小(7例),需随机对照试验确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Patients with CKD suffer from food aversion, anorexia, and malnutrition. Although olfaction has a significant role in determining food flavor, our understanding of olfactory impairment and of the olfaction-nutrition axis in patients with kidney disease is limited. We quantified odor identification, odor threshold, and subjective odor perception in a cohort (n=161) comprising 36 participants with CKD, 100 participants with ESRD, and 25 controls. We investigated olfaction-nutrition associations in these participants and examined a novel intervention to improve olfaction in ESRD. The mean odor identification score was lower in patients with CKD (75.6%±13.1%; P=0.02) and ESRD (66.8%±15.1%; P<0.001) than in controls (83.6%±11.4%). Patients with ESRD exhibited higher odor threshold than the remaining participants exhibited. All groups had similar scores for subjective smell assessment. In multivariable adjusted analyses, kidney disease associated with increased odds of odor identification deficits (odds ratio, 4.80; 95% confidence interval, 1.94 to 11.89). A reduction in odor identification score was associated with higher subjective global assessment score and lower serum total cholesterol, LDL cholesterol, and albumin concentrations. We found no associations between odor threshold and nutritional parameters. In a proof of concept, 6-week, open-label clinical trial, intranasal theophylline (an epithelial membrane transport and proton secretion activator) increased odor identification score in five out of seven (71%) patients with ESRD. In conclusion, patients with kidney disease have olfactory deficits that may influence their nutritional status. Our preliminary results regarding olfactory improvement using intranasal theophylline warrant confirmation in a randomized controlled trial.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Nigwekar SU, Weiser JM, Kalim S, et al. Characterization and Correction of Olfactory Deficits in Kidney Disease. J Am Soc Nephrol. 2017. PMID: 28775001. doi:10.1681/ASN.2016121308

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。